Voici un aperçu des lignes directrices et énoncés scientifiques portant sur les sujets suivants :

• Coronaropathie (maladie coronarienne)
• Maladies valvulaires
• Insuffisance cardiaque
• Cardio-obstétrique
• Réadaptation cardiaque / Prévention secondaire chez les femmes 

Remarque : La liste ne comprend que les lignes directrices et énoncés scientifiques qui incluent des analyses et des recommandations liées au sexe ou au genre. À moins d’indication contraire, les textes sont en anglais seulement.

Coronary Artery Disease

• **NOUVEAU** Canadian Cardiovascular Society/Canadian Women’s Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA)
•  AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021)
• ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes (2019)
• Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the AHA (2018)
• Acute Myocardial Infarction in Women: A Scientific Statement From the AHA (2016) 
• CCS Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease (2014)
• Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease: A Consensus Statement From the AHA (2014)
• ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the ACCF/AHA Task Force on Practice Guidelines (2013)
• Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the AHA (2011)
• ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary (2011)
• Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women: A Statement for Healthcare Professionals From the American Heart Association (2005)

Valvular Heart Disease

• ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the ACC/AHA Joint Committee on Clinical Practice Guidelines (2021)

Heart Failure

• ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: Developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the ESC With the Special Contribution of the HFA of the ESC (2021)
• CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) - (digoxin)
• How to Diagnose Heart Failure With Preserved Ejection Fraction: The HFA-PEFF Diagnostic Algorithm: A Consensus Recommendation From the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2019)
• Sex Differences in Cardiac Arrhythmia: A Consensus Document of the EHRA, Endorsed by the HRS and APHRS (2018)
• Comprehensive Update of the CCS Guidelines for the Management of Heart Failure (2017)

 Cardio-obstétrique

• Société cardiovasculaire du Canada : Clinical Practice Update on Cardiovascular Management of the Pregnant Patient (2021) 
• Société cardiovasculaire du Canada : Diagnosis and Management of HF: Update 2010. HF in ethnic minority populations, HF and pregnancy, disease management and  quality improvement/assurance programs
• Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy
• ESC Clinical Practice Guidelines: Cardiovascular Diseases during Pregnancy (Management of) Guidelines (2018) 
• Pratiques optimales de l’AVC au Canada : Acute Stroke Management During Pregnancy / En français : Prise en charge de l’AVC en phase aiguë durant la grossesse
• Pratiques optimales de l’AVC au Canada : Prevention of Recurrent Stroke in Pregnancy / En français : Prévention de l’AVC pendant la grossesse

  ---

Réadaptation cardiaque / Prévention secondaire chez les femmes

• Women-Focused Cardiovascular Rehabilitation: An International Council of Cardiovascular Prevention and Rehabilitation Clinical Practice Guideline (2022)